Drugs / CKD-320
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04035538 | Aug → Nov 2019 | hypertensive disorder | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-320 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04035538 ↗ |
| Route | Oral | “R: D012 1tablet, QD, PO T: CKD-320 2tablets, QD, PO” NCT04035538 ↗ |